Psychobiological Responses Following Exercise and Brain Stimulation
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Mar 7, 2025
Trial Information
Current as of April 30, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how exercise combined with a specific type of brain stimulation can help reduce symptoms of anxiety. Anxiety disorders are very common and can cause a lot of worry and physical discomfort, affecting people’s daily lives. The researchers want to explore new ways to help those who may not respond well to traditional treatments like medications or therapy.
To participate in this study, you need to be a healthy adult between the ages of 18 and 50. You should not have any neurological or mental health disorders, and you must not be taking medications that affect your brain. Additionally, you should not smoke or drink more than ten alcoholic beverages a week, and women who are pregnant cannot participate. If you join the study, you will be asked to complete some physical activity assessments and may engage in exercise sessions combined with brain stimulation to see if this helps with anxiety.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy adults
- • aged 18 to 50
- • consent and complete a Physical Activity Readiness Questionnaire (PAR-Q)
- • be free from any neurological or psychiatric disorder
- • not be taking any medication that could affect the central nervous system
- • not have any contraindication for HD-tDCS (i.e. not having metal implanted in the head, pacemaker, medical bumps, seizures, lesions on the scalp or head ) or for bioelectrical impedance (i.e., electronic medical implant, such as a pacemaker or implantable cardioverter defibrillator, and limb amputation)
- • not be regular users of tobacco products (cigarettes, cigars, chewing tobacco)
- • not consume an average of more than ten alcoholic beverages per week
- Exclusion Criteria:
- • Individuals who do not meet the PAR-Q screening criteria for participation in moderate physical activity will be excluded from participating in this study
- • women who are pregnant will be exclude from this study
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Trial Officials
Edmund Acevedo
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported